Participant Flow Module
The Participant Flow Module provides information about the flow of participants through each stage of the clinical trial. This includes pre-assignment details, recruitment information, and the types of units analyzed, helping researchers understand how participants move through the study.
Participant Flow Module path is as follows:
Study -> Results Section -> Participant Flow Module
Participant Flow Module
Ignite Creation Date:
2025-12-24 @ 11:07 PM
Ignite Modification Date:
2025-12-25 @ 8:39 PM
NCT ID:
NCT05413369
Pre Assignment Details:
A total of 582 participants were randomized in a 1:1 ratio to receive either insulin glargine/lixisenatide (iGlarLixi) or insulin degludec and insulin aspart (IDegAsp).
Recruitment Details:
The study was conducted at 60 centers in China. A total of 733 participants were screened between 07-Jul-2022 and 17-Apr-2023, of which 151 were screen failures. Screen failures were mainly due to not meeting eligibility criteria.
Study:
NCT05413369
Study Brief:
Results Section:
NCT05413369